Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection - Takeaways - MDSpire

Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection

  • By

  • Jessica A Bryant

  • Timothy J Straub

  • Darrell S Pardi

  • Kevin D Litcofsky

  • Colleen R Kelly

  • Meghan E Chafee

  • Stuart H Cohen

  • Sahil Khanna

  • Charles S Berenson

  • Jennifer Wortman

  • Matthew Sims

  • Christopher B Ford

  • Mary-Jane Lombardo

  • Barbara H McGovern

  • Lisa von Moltke

  • Colleen S Kraft

  • Matthew R Henn

  • Brooke R Hasson

  • August 2, 2025

  • 0 min

Share

  • 1

    Clostridioides difficile infection (CDI) recurrence is influenced by low microbial diversity and altered bile acid concentrations.

  • 2

    Fecal microbiota spores (VOWST®) significantly reduce CDI recurrence rates in patients following antibiotic treatment.

  • 3

    Primary bile acids promote C. difficile spore germination, while secondary bile acids inhibit bacterial growth.

  • 4

    Both first and recurrent CDI patients exhibit similar low microbial diversity and bile acid profiles.

  • 5

    Microbiome restoration through therapies like VOWST is crucial for preventing CDI recurrence and improving treatment outcomes.

Original Source(s)

Comparability of Gastrointestinal Microbiome and Bile Acid Profiles in Patients With First or Multiply Recurrent Clostridioides difficile Infection

  • by Jessica A Bryant, Timothy J Straub, Darrell S Pardi, Kevin D Litcofsky, Colleen R Kelly, Meghan E Chafee, Stuart H Cohen, Sahil Khanna, Charles S Berenson, Jennifer Wortman, Matthew Sims, Christopher B Ford, Mary-Jane Lombardo, Barbara H McGovern, Lisa von Moltke, Colleen S Kraft, Matthew R Henn, Brooke R Hasson

  • August 2, 2025

Related Content

Metabolic and Diagnostic Perspectives on Secondary Lactose Intolerance in Infants Through Fecal Lactose Measurement and Gut Microbiome Analysis

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development

  • April 20, 2026

  • 6 min
AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness